U.S. Physical Therapy (NYSE:USPH) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

U.S. Physical Therapy (NYSE:USPHGet Rating) posted its quarterly earnings data on Thursday. The company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $0.93 by ($0.03), Briefing.com reports. U.S. Physical Therapy had a net margin of 7.69% and a return on equity of 14.77%. The business had revenue of $140.70 million during the quarter, compared to the consensus estimate of $143.01 million. During the same period in the prior year, the company posted $0.96 earnings per share. The firm’s revenue was up 10.9% compared to the same quarter last year. U.S. Physical Therapy updated its FY 2022 guidance to $2.65-$2.75 EPS and its FY 2022 guidance to $2.65-$2.75 EPS.

U.S. Physical Therapy Stock Performance

USPH stock traded down $0.80 during midday trading on Friday, hitting $91.92. The stock had a trading volume of 163,072 shares, compared to its average volume of 80,387. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 31.92 and a beta of 1.22. U.S. Physical Therapy has a 52 week low of $84.43 and a 52 week high of $131.50. The stock has a 50-day simple moving average of $114.70 and a 200 day simple moving average of $104.76. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.40.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 16th. Investors of record on Thursday, August 18th will be given a $0.41 dividend. The ex-dividend date of this dividend is Wednesday, August 17th. This represents a $1.64 annualized dividend and a yield of 1.78%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 56.94%.

Analysts Set New Price Targets

Separately, TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b-” rating in a research report on Thursday, July 28th. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $121.50.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Lazard Asset Management LLC lifted its holdings in shares of U.S. Physical Therapy by 754.7% during the first quarter. Lazard Asset Management LLC now owns 453 shares of the company’s stock valued at $45,000 after acquiring an additional 400 shares during the period. Captrust Financial Advisors lifted its holdings in shares of U.S. Physical Therapy by 348.9% during the first quarter. Captrust Financial Advisors now owns 844 shares of the company’s stock valued at $84,000 after acquiring an additional 656 shares during the period. Prelude Capital Management LLC bought a new position in shares of U.S. Physical Therapy during the first quarter valued at $277,000. Raymond James & Associates bought a new position in shares of U.S. Physical Therapy during the first quarter valued at $279,000. Finally, Hsbc Holdings PLC increased its stake in shares of U.S. Physical Therapy by 62.5% in the first quarter. Hsbc Holdings PLC now owns 3,764 shares of the company’s stock valued at $377,000 after buying an additional 1,447 shares in the last quarter. 99.13% of the stock is owned by institutional investors.

U.S. Physical Therapy Company Profile

(Get Rating)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Earnings History for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.